Emergent BioSolutions (EBS) Misses Q2 EPS, Revenue
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $5.31 -29.58%
Financial Fact:
Provision for (benefit from) income taxes: 13.17M
Today's EPS Names:
GEOS, ARTNA, REFR, More
Financial Fact:
Provision for (benefit from) income taxes: 13.17M
Today's EPS Names:
GEOS, ARTNA, REFR, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q2 EPS of ($0.86), $1.24 worse than the analyst estimate of $0.38. Revenue for the quarter came in at $242.7 million versus the consensus estimate of $270.94 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kodiak Gas Services, Inc. (KGS) Reports Q2 EPS of $0.55
- Perdoceo Education Corp. (PRDO) Tops Q2 EPS by 9c; Offers Guidance
- Alector Inc. (ALEC) Tops Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
